Vicarious Surgical (RBOT) Interest & Investment Income (2020 - 2025)
Vicarious Surgical's (RBOT) quarterly Interest & Investment Income came in at $158000.0 in Q3 2025, down 80.3% year-over-year from $802000.0 in Q3 2024, and down 40.15% quarter-over-quarter from $264000.0 in Q2 2025.
Powered by 
Analysis
Vicarious Surgical (RBOT) Interest & Investment Income (2020 - 2025) Analysis & Trends
Vicarious Surgical (RBOT) has reported Interest & Investment Income for 6 consecutive years, with $158000.0 the latest figure, recorded in Q3 2025.
- On a quarterly basis, Interest & Investment Income fell 80.3% year-over-year to $158000.0 in Q3 2025; TTM through Sep 2025 was $1.5 million, a 60.07% decrease from a year earlier, with the FY2024 full-year figure at $3.3 million, down 25.74% from the prior year.
- Interest & Investment Income was $158000.0 for Q3 2025 at Vicarious Surgical, down from $264000.0 in the prior quarter.
- Over five years, Interest & Investment Income peaked at $1.5 million in Q1 2023 and troughed at -$1000.0 in Q3 2021.
- A 5-year average of $528473.7 and a median of $494000.0 in 2022 frame the typical range for Interest & Investment Income.
- Across the five-year window, Interest & Investment Income sank 200.0% in 2021 and jumped 49500.0% in 2022, its largest moves.
- Over 5 years, Interest & Investment Income stood at $19000.0 in 2021, then soared by 4278.95% to $832000.0 in 2022, then rose by 16.11% to $966000.0 in 2023, then tumbled by 38.51% to $594000.0 in 2024, then sank by 73.4% to $158000.0 in 2025.
- The last three Interest & Investment Income figures came in at $158000.0 (Q3 2025), $264000.0 (Q2 2025), and $446000.0 (Q1 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 52.00 Mn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | - |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 30.00 Mn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | - |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | - |
| 10 | Vicarious Surgical | 231,626.35 | -14.81 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 158,000.00 |
| Jun 30, 2025 | 264,000.00 |
| Mar 31, 2025 | 446,000.00 |
| Dec 31, 2024 | 594,000.00 |
| Sep 30, 2024 | 802,000.00 |
| Jun 30, 2024 | 918,000.00 |
| Mar 31, 2024 | 975,000.00 |
| Dec 31, 2023 | 966,000.00 |
| Sep 30, 2023 | 946,000.00 |
| Jun 30, 2023 | 1.04 Mn |
| Mar 31, 2023 | 1.47 Mn |
| Dec 31, 2022 | 832,000.00 |
| Sep 30, 2022 | 494,000.00 |
| Jun 30, 2022 | 101,000.00 |
| Mar 31, 2022 | 8,000.00 |
| Dec 31, 2021 | 19,000.00 |
| Sep 30, 2021 | -1,000.00 |
| Jun 30, 2021 | 1,000.00 |
| Mar 31, 2021 | 1,000.00 |
| Dec 31, 2020 | -1,000.00 |